S.T.D.

• Surface-Active Agents
• Sclerosing Agents
• ATC:C05BB04

• Monotetradecylsulfate sodium salt
• Myristyl sulfate, sodium salt
• Niaproof-4
• S.T.D.
• Sodium myristyl sulfate
• Sodium tetradecyl sulfate
• Sodium tetradecyl sulfate 99%
• Tetradecyl sulfate
• Tergitol-4
• Tetradecyl hydrogen sulphate
• Tetradecyl sodium sulfate
• Tetradecyl sulfate, sodium salt
• Tetradecyl sulfuric Acid
• Texapon K 14

• No information avaliable

C₁₄H₃₀O₄S

http://www.rxlist.com/cgi/generic2/sotradecol.htm

S.T.D. MSDS

No information avaliable

294.452 g/mol

No information avaliable

No information avaliable

Solid

No information avaliable

Solution for intramuscular injection

For the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves.

Sodium tetradecyl sulfate is an anionic surfactant which occurs as a white, waxy solid. It is used as a sclerosing agent in sclerotherapy. Sclerotherapy is an injection of a sclerosing agent directly through the skin into a lesion and is used primarily for slow-flow vascular anomalies, particularly for venous malformation and lymphatic malformation. Intravenous injection causes intima inflammation and thrombus formation. This usually occludes the injected vein. Subsequent formation of fibrous tissue results in partial or complete vein obliteration that may or may not be permanent.

No information avaliable

LD₅₀=1250 mg/kg (Orally in rat); LD₅₀=3 ml/kg (Skin in rat)

No information avaliable

Humans and other mammals